This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Obara, A. Articles by Hasebe, N. Search for Related Content PubMed PubMed Citation Articles by Obara, A. Articles by Hasebe, N.

Circulation, Vol 85, 606-611, Copyright © 1992 by American Heart Association

ARTICLES

Effect of xamoterol in Shy-Drager syndrome

A Obara, H Yamashita, S Onodera, O Yahara, H Honda and N Hasebe
First Department of Internal Medicine, Asahikawa Medical College, Japan.

BACKGROUND. Xamoterol, a cardioselective beta 1-adrenoceptor partial agonist, has been reported to be effective on postural hypotension. We investigated the effect of xamoterol in five patients with Shy-Drager syndrome (SDS) in relation to their prevailing sympathetic nerve activity and sensitivity of beta-adrenoceptors and the change in circadian variation of blood pressure. METHODS AND RESULTS. Ambulatory blood pressure over 24 hours was monitored by noninvasive sphygmomanometer (model 5200, Spacelab). Plasma norepinephrine levels of SDS patients were significantly lower than that of normal subjects (n = 5) both at rest (54 +/- 15 versus 178 +/- 83 pg/ml) and after 10- minute standing (74 +/- 24 versus 318 +/- 143 pg/ml). Infusion of isoproterenol (0.02 micrograms/kg/min) produced a mild rise of systolic blood pressure and tachycardia in normal subjects but resulted in marked hypotension and tachycardia in SDS subjects. After xamoterol administration (200 mg b.i.d.), systolic blood pressure and heart rate were significantly increased in the averages during the day; however, increases were more pronounced at night. In two of the five patients, the improvement in dizziness was large enough to enable them to increase their daily activities. CONCLUSIONS. Our observations suggest that 1) beta 1-selective, high intrinsic sympathomimetic activity of xamoterol increases blood pressure and heart rate in patients with SDS as a consequence of their prevailing beta 1-adrenoceptor hypersensitive state, and 2) blood pressure monitoring over 24 hours appears to have important advantages in evaluating the therapeutic effects on postural hypotension.

This article has been cited by other articles:

				F. Yamasaki, T. Ushida, T. Yokoyama, M. Ando, K. Yamashita, and T. Sato Artificial Baroreflex: Clinical Application of a Bionic Baroreflex System Circulation, February 7, 2006; 113(5): 634 - 639. [Abstract] [Full Text] [PDF]

				Y. Yanagiya, T. Sato, T. Kawada, M. Inagaki, T. Tatewaki, C. Zheng, A. Kamiya, H. Takaki, M. Sugimachi, and K. Sunagawa Bionic epidural stimulation restores arterial pressure regulation during orthostasis J Appl Physiol, September 1, 2004; 97(3): 984 - 990. [Abstract] [Full Text] [PDF]

				T. Sato, T. Kawada, M. Sugimachi, and K. Sunagawa Bionic Technology Revitalizes Native Baroreflex Function in Rats With Baroreflex Failure Circulation, August 6, 2002; 106(6): 730 - 734. [Abstract] [Full Text] [PDF]

				T. Sato, T. Kawada, T. Shishido, M. Sugimachi, J. Alexander Jr, and K. Sunagawa Novel Therapeutic Strategy Against Central Baroreflex Failure : A Bionic Baroreflex System Circulation, July 20, 1999; 100(3): 299 - 304. [Abstract] [Full Text] [PDF]